Cefepime versus piperacillin-tazobactam for the treatment of <i>Pseudomonas aeruginosa</i> pneumonia

Raneem H Pallotta, Walaiporn Wangchinda, Samantha R Sallerson, Gregory E Eschenauer, Vincent D Marshall, Virginia M Pierce, Jason M Pogue, Samuel L Aitken

Open source

DOI
10.1093/cid/ciag535
Published
2026-09-02
Container
Clinical Infectious Diseases
Publisher
Oxford University Press (OUP)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/cid/ciag535,
  title = {Cefepime versus piperacillin-tazobactam for the treatment of
                    <i>Pseudomonas aeruginosa</i>
                    pneumonia},
  author = {Raneem H Pallotta and Walaiporn Wangchinda and Samantha R Sallerson and Gregory E Eschenauer and Vincent D Marshall and Virginia M Pierce and Jason M Pogue and Samuel L Aitken},
  year = {2026},
  journal = {Clinical Infectious Diseases},
  doi = {10.1093/cid/ciag535},
  url = {https://doi.org/10.1093/cid/ciag535}
}

RIS

TY  - JOUR
TI  - Cefepime versus piperacillin-tazobactam for the treatment of
                    <i>Pseudomonas aeruginosa</i>
                    pneumonia
AU  - Raneem H Pallotta
AU  - Walaiporn Wangchinda
AU  - Samantha R Sallerson
AU  - Gregory E Eschenauer
AU  - Vincent D Marshall
AU  - Virginia M Pierce
AU  - Jason M Pogue
AU  - Samuel L Aitken
PY  - 2026
JO  - Clinical Infectious Diseases
DO  - 10.1093/cid/ciag535
UR  - https://doi.org/10.1093/cid/ciag535
ER  - 

APA

Pallotta, R. H., Wangchinda, W., Sallerson, S. R., Eschenauer, G. E., Marshall, V. D., Pierce, V. M., Pogue, J. M., & Aitken, S. L. (2026). Cefepime versus piperacillin-tazobactam for the treatment of <i>Pseudomonas aeruginosa</i> pneumonia. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciag535

Source records